RecruitingNot Applicable

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

United States456 participantsStarted 2023-09-07

Plain-language summary

This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing an evidence-based intervention to improve these residents' sleep. It will also examine the implementation and sustainment of this intervention.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Nursing home residents aged \>=50 years with an Alzheimer disease or related dementia (ADRD) diagnosis, identified by nursing home staff participating in frontline LOCK sleep huddles as having sleep problems Exclusion Criteria: * Residents with a high risk of OSA who are not being treated for OSA because actigraph measurements are inaccurate in that population. * Residents who have a persistent bilateral resting tremor or paralysis in both arms (a subset of persons with Parkinson's disease and related significant tremor-causing diagnoses), due to actigraph measurement inaccuracies

What they're measuring

Sleep (actigraph measurement)

Timeframe: 15 week sleep intervention period

Trial details

NCT IDNCT05820919

SponsorUniversity of Alabama, Tuscaloosa

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-01

Contact for this trial

Lynn Snow, PhD

205-201-0312 LSNOW@ua.edu

View on ClinicalTrials.gov More Alzheimer Disease trials